Holen Sie sich die Stockscreener-App
11.23
2.28%
0.25
Schlusskurs vom Vortag:
$10.98
Offen:
$10.98
24-Stunden-Volumen:
1.05M
Relative Volume:
0.78
Marktkapitalisierung:
$1.09B
Einnahmen:
$47.56M
Nettoeinkommen (Verlust:
$-156.83M
KGV:
-6.1366
EPS:
-1.83
Netto-Cashflow:
$-127.98M
1W Leistung:
+8.19%
1M Leistung:
+22.33%
6M Leistung:
+40.38%
1J Leistung:
-31.82%
1-Tages-Spanne:
$10.82
$11.25
1-Wochen-Bereich:
$10.32
$11.48
52-Wochen-Spanne:
$6.38
$17.30
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Firmenname
Avadel Pharmaceuticals Plc
Sektor
Telefon
636-449-1830
Adresse
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Vergleichen Sie AVDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
11.23 | 1.01B | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-12 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-05 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-05 | Bestätigt | Needham | Buy |
| 2024-03-05 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2022-11-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-28 | Fortgesetzt | Craig Hallum | Buy |
| 2022-05-26 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2020-07-21 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-03 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Eingeleitet | Stifel | Buy |
| 2020-02-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-30 | Eingeleitet | Craig Hallum | Buy |
| 2019-06-14 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
Alle ansehen
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Avadel Pharmaceuticals plc Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
Is Avadel Pharmaceuticals plc a good long term investmentTriple-digit profit margins - jammulinksnews.com
What analysts say about Avadel Pharmaceuticals plc stockSuperior investment outcomes - Autocar Professional
Insider Stock Buying Reaches US$761.7k On Avadel Pharmaceuticals - simplywall.st
Avadel Pharmaceuticals Plc (NASDAQ:AVDL) Has Found A Path To Profitability - 富途牛牛
Avadel Pharmaceuticals (NASDAQ:AVDL) Now Covered by HC Wainwright - MarketBeat
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Teacher Retirement System of Texas Lowers Holdings in Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Upgraded at HC Wainwright - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Research Coverage Started at HC Wainwright - Defense World
Avadel Stock Climbs as Appeals Court Backs FDA Approval of LUMRYZ - MSN
HC Wainwright Initiates Buy Rating on Avadel Pharmaceuticals with $22 Price Target - AInvest
What drives Avadel Pharmaceuticals plc stock priceRobust investment performance - jammulinksnews.com
Avadel Pharmaceuticals: HC Wainwright assumes Buy, PT at $22. - AInvest
How Avadel Pharmaceuticals plc stock performs during market volatilityStrategic High Profit Opportunities - beatles.ru
Why Avadel Pharmaceuticals plc stock attracts strong analyst attentionDaily Gain Forecast - Newser
What makes Avadel Pharmaceuticals plc stock price move sharplyConsistent Growth Alert - Newser
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Given Average Rating of “Buy” by Analysts - Defense World
ASL Strategic Value Fund Files an Exempt Solicitation Statement with Securities and Exchange Commission - MarketScreener
ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders - Business Wire
(AVDL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Avadel Pharmaceuticals Receives Unanimous Appeals Court Affirmation for LUMRYZ FDA Approval - Yahoo
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - Yahoo Finance
Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 - MSN
How To Trade (AVDL) - news.stocktradersdaily.com
Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On LumryzAvadel Pharmaceuticals (NASDAQ:AVDL) - Benzinga
Institutional owners may take dramatic actions as Avadel Pharmaceuticals plc's (NASDAQ:AVDL) recent 7.2% drop adds to one-year losses - simplywall.st
Investor urges Avadel shareholders to vote against directors By Investing.com - Investing.com South Africa
ASL pushes for board shakeup at Avadel over handling of sleep drug rollout - MarketScreener
Avadel stock rises after appeals court upholds LUMRYZ approval - Investing.com
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation - The Manila Times
Avadel Pharmaceuticals faces board challenge from investor ASL Strategic Valuereport By Investing.com - Investing.com UK
Avadel Pharmaceuticals Wins Appeal on LUMRYZ Approval, Reaffirming FDA Approval of the Drug. - AInvest
Form DEFA14A AVADEL PHARMACEUTICALS - StreetInsider
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High? - Yahoo Finance
Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock - Yahoo Finance
Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):